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Background: Liver involvement in acute dengue infection is frequently observed and sometimes leads to acute liver
failure, with fatal outcomes. Many factors are thought to contribute to liver dysfunction, including hypoxic injury due to
decreased perfusion, direct damage by the virus and immune mediated injury. In this study, we sought to identify the
pattern in the change in liver enzymes throughout the illness and its association with the degree of viraemia, onset
and extent of plasma leakage and inflammatory mediators.
Methods: Serial daily blood samples were obtained from 55 adult patients with acute dengue from the time of
admission to discharge and the liver function tests, viral loads and cytokines were assessed. The onset and extent of fluid
leakage was measured by daily ultrasound examinations and all clinical and laboratory features were serially recorded.
Results: Aspartate transaminase (AST), alanine transaminase (ALT) and gamma glutamyl transferase (GGT) levels were
elevated in patients with dengue infection throughout the illness. The highest AST levels were seen on day 6 of illness
and both AST and GGT levels were significantly higher in patients with severe dengue (SD), when compared to those
with non-severe dengue (NSD) on day 5 and 6 of illness. Three patients with SD had AST and ALT values of >1000/IU in
the absence of any fluid leakage or a rise in the haematocrit (≥20 %). The peak of the AST levels and the lowest serum
albumin levels were seen 24 h before the maximum fluid leakage and 24 h after the peak in viraemia. Both serum IL-10
and IL-17 levels were elevated during early illness and were significantly higher in those with SD when compared to NSD.
Conclusion: Dengue associated liver injury appears to peak around day 6 and 7. Therefore, liver function tests done
at earlier dates might not reflect the extent of liver involvement in acute infection. Since severe liver involvement can
occur in the absence of fluid leakage, after the peak viraemia, and since it is associated with high IL-17 and IL-10 levels,
possible immune mechanisms leading to hepatic damage should be investigated.
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Dengue viral infections are one of the most rapidly evolving
vector borne infections, which now affects 125 countries,
causing approximately 100 million apparent infections each
year [1]. It is predicted that the transmission of dengue will
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spread to countries that are currently not significantly
affected by dengue in Europe and America [1]. Currently
there is no specific antiviral or any other drug that is ef-
fective in the treatment of acute dengue infection.
Infection with the DENV results in asymptomatic disease
or an undifferentiated viral fever like illness in the majority
of infected individuals. However, in others, it may result in
dengue fever (DF), dengue haemorrhagic fever (DHF) lead-
ing to shock (DSS), or the expanded dengue syndrome [2].
Involvement of the liver leading to hepatic dysfunction is a
well-recognized complication of dengue [3–5]. Dengue as-
sociated acute liver failure has a high mortality due tole is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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renal failure and metabolic acidosis [3, 4]. Although dengue
associated acute liver failure is thought to occur due to liver
injury as a result of prolonged shock, it is also known to
occur in the absence of shock [4].
Varying degrees of liver involvement are seen during
acute dengue infection and are thought to result from
hepatocyte apoptosis directly by the virus, hypoxic damage
due to impaired liver perfusion resulting from fluid leak-
age, oxidative stress or immune mediated injury [6–8].
Studies done in mouse models have proposed that dengue
associated liver injury can be both viral induced or im-
mune mediated. The dengue virus (DENV) has been
shown to readily infect hepatocytes in mouse models, and
HepG2 and Huh7 hepatoma cell lines [9–11]. In both
mouse models and hepatoma cell lines, apoptosis of hepa-
tocytes was shown to be due to both direct viral infection
and also cytokine induced [12]. It has been shown that in
dengue mouse models, that both IL-22 and IL-17 were
associated with severe clinical disease, and particularly
liver injury [13]. In addition, liver involvement was found
to be significantly reduced following IL-17 receptor block-
ade [13]. Again in dengue mouse models, early infiltration
of the liver by natural killer cells followed by T cells was
observed, and was found to associate with apoptosis of
hepatocytes [14]. Cytokine mediated liver damage has also
been proposed as a mechanism, as high levels of IP-10 and
IL-10 were found to associate with high liver transaminase
levels in children with dengue [15]. Many believe that den-
gue associated liver dysfunction is probably due to reduced
perfusion associated hypoxic injury as a consequence of a
severe vascular leak [2].
However, since the frequency of liver involvement associ-
ated with dengue is increasing and since isolated liver
involvement in the absence of shock and other dengue
associated complications (expanded dengue syndrome) is
also increasing [2], it has become important to identify the
causes of liver involvement in dengue, including the kinet-
ics in changes in liver function tests associated with acute
dengue infection. Therefore, in this study, we serially stud-
ied a cohort of adult dengue patients with severe dengue
(SD) and non-severe dengue (NSD), who did not develop
shock during the course of their illness, and investigated
the changes in liver enzymes during the natural course of
the illness and determined the degree of liver damage in as-
sociation with the degree of viraemia, the onset and extent
of vascular leak and changes in inflammatory mediators.
Methods
Patients
Fifty five adult patients with acute dengue infection were
recruited from the Infectious Diseases Hospital of Sri
Lanka in year 2015 from January to August, following
informed written consent. Those who were known to havechronic liver disease, chronic renal disease, pregnant indi-
viduals, those on a steroid dose of >40 mg/day for over
7 days and those who had been given NSAIDs for the
treatment of dengue prior to admission, were excluded
from the study. None of the patients were given any drugs
except for the recommended dose of paracetamol. Only
those whose duration from onset of illness was ≤5 days
were recruited. The day in which the patient first devel-
oped fever was considered as day one of illness. As one of
the main aims of this study was to determine the timing of
liver injury with changes in viral load, vascular leak and in-
crease in inflammatory mediators, the clinical features
along with these parameters were recorded daily. Blood
samples were obtained daily at 10 am from the day of
recruitment until discharge from the hospital. As the max-
imum duration of illness in this cohort was 9 days, no
samples were analysed beyond day 9 of illness. The
number of patients assessed at each time point is given
in Additional file 1: Table S1.
Clinical features such as fever, blood pressure, pulse
pressure and the urine output were measured at least 4
times a day. Serial recordings of liver function tests, viral
loads, the extent of fluid leakage and serum cytokine levels
were done daily. In order to determine the relationship
between plasma leakage and liver derangements, we car-
ried out serial ultrasound scans of all patients to define the
onset and extent of fluid leakage. Ultrasound scanning was
done in the supine position to assess the peritoneal fluid in
the hepatorenal angle, subdiaphragmatic position, in para-
colic gutters and in the pelvis. In order to determine the
fluid in the pleural cavity the patient was kept seated
upright on the examination bed for 2 min for all the
pleural fluid to gravitate in to costodiaphragmatic recesses
and then the patient was scanned from the back of the
chest with hands raised up and crossed at the back of the
head. Fluid was measured at the mid and posterior axillary
lines and in seated-up position. Fluid accumulation in the
peritoneal cavity was assessed by a semi quantitative man-
ner, with classification of ascites as minimal, mild, moder-
ate, severe and massive by looking for the presence of fluid
in five areas of the abdomen namely right upper quadrant
(perihepatic and morrison’s pouch), left upper quadrant
(perisplenic), right paracolic gutter, left paracolic gutter
and pelvis.
Severity of dengue infection was classified according to the
2009 WHO guidelines [16]. Accordingly, patients who had
detectable fluid in the pleural or abdominal cavities by ultra-
sound scanning, or who had liver transaminases above
>1000/IU were grouped as having SD. Those who had den-
gue with warning signs or without warning signs were classi-
fied as having non severe dengue (NSD). Signs of severe
dengue were characterized by the presence of cold clammy
skin, along with a narrowing of pulse pressure ≤ 20 mmHg
were classified as having shock as per WHO 2009 guidelines.
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assays
Acute dengue infection was confirmed in the serum sam-
ples using the NS1 early dengue ELISA (Panbio, Australia)
and by determining viral loads (see below). In order to de-
termine if the patients had a primary or secondary dengue
infection, the commercial capture-IgM and IgG enzyme-
linked immunosorbent assay (ELISA) (Panbio, Brisbane,
Australia) was used. The ELISA was performed and the
results were interpreted according to the manufacturers’
instructions. This ELISA assay has been validated as both
sensitive and specific for primary and secondary dengue
virus infections [17, 18].
Determining viral loads in serial blood samples
As we wished to determine the changes in viral loads in
patients with SD and non-SD during the course of the ill-
ness, RNA was extracted from all serial serum samples
using QIAamp Viral RNA Mini Kit (Qiagen, USA) accord-
ing to the manufacturer’s protocol. The RNA was reverse
transcribed into cDNA in GeneAmp PCR system 9700
using High Capacity cDNA reverse transcription kit
(Applied Biosystems, USA) according to the manufac-
turer’s instructions. Reaction conditions were 10 min at
25 °C, 120 min at 37 °C, 5 min at 85 °C and final hold
at 4 °C.
Multiplex quantitative real-time PCR was performed
as previously described using the CDC real time PCR
assay for detection of the dengue virus [19]. This assay
was modified to quantify the DENV apart from quantita-
tive analysis. Oligonucleotide primers and a dual labeled
probe for DEN 1,2,3,4 serotypes were used (Life tech-
nologies, India) based on published sequences [19]. The
probe was dual-labeled with the probe and the QSY
quencher. The DENV serotype specific primers were la-
beled as follows: DENV-1 with JUN, DENV-2 with ABY,
DENV-3 with FAM, DENV-4 with VIC. The reactions
consisted of 20 μl volumes and contained the following
reagents, TaqMan multiplex master mix (containing
mustag dye), 900 nM of each primer, 250 nM of each
probe, 2 μl of cDNA and nuclease free water (Applied
Biosystems, USA). The reaction was performed in an
Applied Biosystems7500, 96-well plate detection system.
Following initial denaturation for 20 s at 95 °C, the reac-
tion was carried out for 40 cycles of 3 s at 95 °C and
30 s at 60 °C. The threshold cycle value (Ct) for each re-
action was determined by manually setting the threshold
limit. Viral quantification (PFU/ml) of unknown samples
was performed using the standard curve.
Generating standard curves for quantification of the DENV
For generation of standard curves the four DENVs were
grown in C6/36 cell lines supplemented with L15 media
at 28 ° C. The virus supernatants were harvested at day7 following infection and were immediately used to infect
vero81 cell lines to determine the infective virus particles
by plaque assays. The plaque assay was carried out on
vero81 monolayer and the virus culture supernatants were
serially diluted and inoculated in triplicate. Undiluted
sample from the virus culture supernatant was used as the
positive control and culture media as the negative control.
After 5 days of incubation at 37 °C in 5 % CO2 incubator,
the plaques were developed and counted. Virus concen-
tration was calculated as PFU/ml. Following quantification
of the viruses, the standard curves were generated as serial
dilutions from 106 to 101 of pfu/ml of each virus serotype.
In order to quantify the virus in clinical samples the un-
knowns were compared to known values in the standard
curves of each virus and the viral loads expressed as pfu/
ml (Additional file 2: Figure S1).
Assays for determining the liver profile
Assessment of the liver profile was done on all serial blood
samples on a daily basis, obtained from the time of recruit-
ment to discharge from hospital. Liver function tests to
assess liver cell damage: aspartate transaminase (AST), ala-
nine transaminase (ALT); tests to assess synthetic func-
tions: serum albumin; tests to assess conjugative functions:
conjugated and unconjugated bilirubin and tests to assess
intrahepatic and hepatobiliary cholestasis: gamma glutamyl
transferase (GGT) and alkaline phosphatase (ALP) were
done using automated biochemical analyzer (Thermo sci-
entific clinical chemistry analyzer-Indiko, United States).
Quantitative ELISA for detection of cytokines
IL-10 and IL-17 levels were determined in serial serum
samples, which were collected daily from the time of
admission to discharge, using the human IL-10 enzyme
linked immunosorbent assay (ELISA) PRO kit (Mabtech,
Sweden) and LEGEND MAX™ Human IL-17A ELISA
Kit (BioLegend, USA). The ELISAs were performed and
results were interpreted according to the manufacturer’s
instructions.
Statistical analysis
Statistical analysis was performed using Graph PRISM
version 6. Differences in the serial values of liver enzymes,
viral loads and cytokine values in patients with NSD and
SD were done using multiple unpaired t tests. Corrections
for multiple comparisons were done using Holm-Sidak
method and the statistical significant value was set at 0.05
(alpha). The association between the extent of liver injury
and clinical parameters, viral loads and inflammatory me-
diators was done using Spearman correlation.
Results
Based on the WHO 2009 guidelines, 33 patients had NSD
and 22 had SD. None of the patients developed shock
Table 2 Haematological changes in patients with SD and NSD
Laboratory features NSD (n = 33) SD (n = 22)
Lowest platelet count
<20,000 cells/mm3 1 (3.03 %) 15 (68.18 %)
20,000 to 50,000 12 (36.36 %) 7 (31.81 %)
50,000–100,000 15 (45.45 %) 0
>100,000 15 (45.45 %) 0
Lowest Lymphocyte count
<750 13 (39.39 %) 12 (54.54 %)
750–1500 19 (57.57 %) 9 (40.90 %)
>1500 1 (3.03 %) 0
Table 3 Biochemical findings in patients with SD and NSD
Biochemical findings NSD (n = 33) SD (n = 22)
AST (IU/L)
<40 5 (15.15 %) 0
40–160 15 (45.45 %) 6 (27.27 %)
>160 13 (39.39 %) 16 (72.72 %)
ALT (IU/L)
<40 7 (21.21 %) 3 (13.63 %)
40–160 23 (69.96 %) 11 (50 %)
>160 3 (9.09 %) 8 (36.36 %)
Albumin (g/L)
<35 18 (54.54 %) 22 (100 %)
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one had hypertension while 2 patients with NSD had dia-
betes and one had hypertension. The clinical features of
the 33 patients (mean age 33.60, SD ± 13.26) with NSD and
22 patients with SD (mean age 30.36, SD ± 14.23) are
shown in Table 1. Of the 22 patients with SD, 3 of them did
not have any evidence of fluid leakage but were classified as
having SD as their liver transaminases were elevated
>1000/IU. 10 patients with SD were given dextran boluses
and 4 of them were given blood transfusions, although
none of them developed shock. The haematological and
biochemical parameters of these patients are shown in
Tables 2 and 3. Although 5 patients with NSD developed
bleeding manifestations, these were mild bleeding manifes-
tations and as the patients did not have any evidence of
fluid leakage, by ultrasound scanning or by a rise in the
haematocrit, they were categorized as having NSD.
Patterns of changes in liver transaminase levels during the
course of the illness
As elevation of liver transaminases commonly occurs
during dengue infections, we sought to investigate the
kinetics of liver transaminases in acute dengue infection
and the relationship in the rise in these enzymes with
viraemia, onset of fluid leakage and changes in inflam-
matory mediators. Both AST and ALT levels rose during
the course of illness and AST peaked at day 6 of illness,
while ALT peaked at day 7. After peaking at day 6 and 7
the AST and ALT levels rapidly declined (Fig. 1a and b).
The AST levels were much higher in patients with SD
than in those with NSD with the differences most prom-
inent on day 5 (p = 0.04) and day 6 (p = 0.006) (Fig. 1a).
The mean AST levels on day 6 (mean 263.44, SD ±
34.1 IU) were more than two fold when compared to the
mean AST values on day 4 (mean 123.4, SD ± 41.8 IU)
in patients with SD. The differences in ALT levels in
patients with SD and NSD were not prominent (Fig. 1b).
AST: ALT ratio has been considered as a better indicatorTable 1 Clinical characteristics of patients with SD and NSD
Clinical findings NSD (n = 33) SD (n = 22)
Duration of fever
3–5 days 25 (75.75 %) 15 (68.18 %)
6–8 days 8 (24.24 %) 6 (27.27 %)
>8 days 0 1 (4.54 %)
Vomiting 9 (27.27 %) 11 (50 %)
Abdominal pain 12 (36.36 %) 16 (72.72 %)
Hepatomegaly 5 (15.15 %) 15 (68.18 %)
Bleeding manifestations 5 (15.15 %) 7 (31.81 %)
Pleural effusion 0 15 (68.18 %)
Ascites 0 19 (86.36 %)
Shock 0 0of the type of liver injury than changes in AST or ALT
alone [20, 21]. We found that the AST: ALT ratio was >2 in
patients with SD and NSD, although the ratios were higher
in those with DHF (Fig. 1c). As expected the AST levels
positively correlated with other indicators of liver disease
such as ALT (Spearmans correlation = 0.61, p < 0.0001),
GGT (Spearmans correlation = 0.57, p < 0.0001), total bili-
rubin (Spearmans correlation =0.27, p < 0.0001) and also
with IL-10 (Spearmans correlation = 0.15, p = 0.04).≥35 14 (42.42 %) 0
Total protein (g/L)
<64 21 (63.63 %) 21 (95.45 %)
≥64 12 (36.36 %) 1 (4.54 %)
Alkaline phosphatase (IU/L)
<128 31 (93.93 %) 18 (81.81 %)
≥128 2 (6.06 %) 4 (18.18 %)
Total bilirubin (μmol/L)
<20 31 (96.87 %) 21 (95.45 %)
>20 1 (3.12 %) 1 (4.54 %)
Gamma glutamyl transferase (u/L)
normal value for sex 9 (27.27) 2 (9.09 %)
>normal value for sex
(female≤ 38 and male ≤55)
24 (72.72 %) 20 (90.9 %)
Fig. 1 Changes in serum transaminase levels throughout the course of illness in patients with acute dengue infection. a: Changes in serum
aspartate transaminase levels (AST) in patients with SD (n = 22) and NSD (n = 33). The lines indicate the means and standard error of mean (SEM).
b: Changes in serum alanine transaminase levels (ALT) in patients with SD (n = 22) and NSD (n = 33). The lines indicate the means and standard
error of mean (SEM). c: Changes in AST and ALT ratios in patients with SD (n = 22) and NSD (n = 33). The lines indicate the means and standard
error of mean (SEM)
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levels and alkaline phosphatase (ALP) levels
Although GGT is not specific to the liver, it has widely
been used as a test to assess the liver profile. High levels
are found with cholestasis, excessive alcohol intake, pan-
creatitis, diabetes and many other conditions [22]. Since
it is also known to be elevated in oxidative stress [22],
and since oxidative stress is thought to play a role in the
pathogenesis of dengue [8, 23], we sought to investigate
the changes of GGT in patients with acute dengue. We
found that GGT levels were elevated throughout the
course of infection in patients with both SD and NSD
(Fig. 2a). The levels were significantly higher on day 6
(p = 0.02) and day 7 (p = 0.03) in patients with SD when
compared to those with NSD. Twenty (90.9 %) of the pa-
tients with SD (12 males and 8 females) and 24 (72.7 %)
of patients with NSD (15 males and 9 females) had ele-
vated GGT levels.
ALP is not a liver specific enzyme and is found in many
tissues such as bone, intestine and placenta apart from the
liver [24]. ALP is generally elevated in hepatobiliary diseases
that result in cholestatis [24]. Although 2 patients with
NSD and 4 patients with SD had a mild elevation of ALP
levels, all other patients had normal ALP levels throughout
the course of illness, which suggests that cholestasis is un-
likely to occur in dengue induced liver disease (Fig. 2b).Changes in bilirubin, serum albumin, plasma leakage and
viraemia during the course of acute dengue
Elevation of serum bilirubin occurs due to defects in cho-
lestasis and biliary effects. However, in acute liver disease,
it is considered to be a more sensitive marker than ALT in
determining the extent of liver injury [25, 26]. However,
we found that the total serum bilirubin levels were only
marginally high in one patient with SD and one with NSD.
These patients also had normal conjugated and unconju-
gated bilirubin levels, further supporting that cholestatis or
biliary stasis, did not significantly occur in dengue associ-
ated liver disease.
Low serum albumin levels have been associated with
severe dengue and were more frequent among those who
had fatal dengue [27, 28]. As expected the serum albumin
levels were significantly lower in patients with SD, espe-
cially during day 5 (p = 0.04), day 6 (p = 0.06) and day 7 (p
= 0.04), while the values were normal in those with NSD
(Fig. 3a). Interestingly, the lowest serum albumin levels
were seen 2 days before the maximum peak in the fluid
leakage (Fig. 3b). It is generally believed that liver dysfunc-
tion sometimes leading to acute liver failure is due to
reduced hepatic perfusion secondary to prolonged shock
[2]. However, it has been known to occur in the absence of
shock [4]. Three of the patients in our cohort had severe
liver impairment (liver transaminases >1000/IU) in the
Fig. 2 Changes in serum GGT and ALP levels throughout the course of
illness in patients with acute dengue infection. a: Changes in serum GGT
levels in patients with SD (n= 22) and NSD (n= 33). The lines indicate
the means and standard error of mean (SEM). b: Changes in serum ALP
levels in patients with SD (n= 22) and NSD (n= 33). The lines indicate
the means and standard error of mean (SEM)
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nificant rise in the haematocrit. However, in those with SD,
the maximum rise in AST and ALT levels occurred the day
before the pleural effusions were largest (Fig. 3c). However,
the rise in GGT levels mirrored the increase in the pleural
effusions.
As studies done on HepG2 cell lines have shown that
the DENV directly induced apoptosis of HepG2 cells [29],
we proceeded to determine the relationship between the
kinetics of viraemia with the changes in the patterns of
liver enzymes. We found that the rise in liver transami-
nases and GGT occurred 24–48 h after the decline in the
viraemia (Fig. 3d). Also, there was no association between
the extent of viraemia and the extent of the rise in liver
transaminases, GGT or a reduction in serum albumin
levels. However, the viral loads inversely correlated with
the lowest lymphocyte count observed in these patients
(Spearman’s correlation = −0.6, p < 0.0001).
Changes in IL-10 and IL-17 levels and extent of liver
involvement
Our previous studies and others have shown that elevated
IL-10 is associated with severe dengue [30, 31], and there-
fore, we sought to investigate the changes in IL-10 levelsthroughout the clinical disease and its association with
liver damage. We found that IL-10 levels were elevated in
the early course of the illness with IL-10 values being
significantly higher on day 5 of illness in patients with SD
(p = 0.03), when compared to those with NSD (Fig. 4a). As
seen in our previous studies, we found that IL-10 inversely
correlated with the lowest lymphocyte counts (Spearman’s
correlation =0.58, p < 0.0001). However, except with being
associated with AST levels (Spearman’s correlation =0.14,
p = 0.04), IL-10 did not associate with any other liver en-
zyme or clinical parameter.
It has been shown in dengue mouse models that both
IL-22 and IL-17 are associated with severe clinical dis-
ease and in particularly liver injury [13]. Therefore, we
determined the kinetics of changes in IL-17 in acute
dengue and its association with liver injury. We found
that similar to IL-10, IL-17 was significantly elevated
during the early phase of dengue infection. IL-17 levels
were significantly elevated in patients with SD on day 4
(p = 0.02) and day 5 (p = 0.02) when compared to those
with NSD (Fig. 4b). IL-17 levels correlated with serum
IL-10 levels (Spearmans correlation =0.26, p = 0.0002),
viral loads (Spearmans correlation = 0.26, p = 0.005) and
ALT (Spearmans correlation =0.16, p = 0.02).
Discussion
In this study, we have determined the changes in liver
enzymes over the course of acute dengue infection and
also the relationship of liver involvement with the degree
of viraemia, onset and extent of fluid leakage and levels
of cytokines. We found that all patients with SD (but
who did not have shock) had some degree of liver in-
volvement, while only 15.1 % of those with NSD did not
have any liver involvement.
ALT and AST are considered as indicators of liver cell
injury as they are released into the circulation following
liver cell injury [25]. Although ALT is also found in low
concentrations in skeletal muscle, brain and intestinal
tissue, it is predominantly considered to be a liver specific
enzyme [25]. In contrast, AST is released following dam-
age to liver, cardiac and skeletal muscle [25]. We found
that the rise in AST was more prominent than the rise in
ALT levels in patients with SD, which probably suggests
that other sources apart from the liver could also be con-
tributing to the rise in serum AST levels. Importantly, the
mean AST levels rose more than twofold from day 4 to
day 6 of onset of illness, and the three patients whose liver
transaminases were >1000/IU, had AST levels around
200–250 IU during day 4 of illness. Therefore, determin-
ing liver transaminase levels on day 4 or day 5 (day of
admission) alone might very much underestimate the level
of liver injury during acute dengue infection.
In this study, we also assessed the changes in GGT,
ALP, serum bilirubin and serum albumin levels and none
Fig. 3 Association of liver damage with extent of fluid leakage and viraemia. a: Changes in serum albumin levels in patients with SD (n = 22) and NSD
(n = 33). The lines indicate the means and standard error of mean (SEM). b: Extent of pleural effusion in patients with SD (n = 15, as 3 patients with SD
did not have any leakage). The values indicate the height of pleural effusion in cm, over the course of illness. c: Changes in serum AST, ALT and GGT
levels in patients with SD (n = 22). d: Changes in viral loads in patients with SD (n = 22)
Fernando et al. BMC Infectious Diseases  (2016) 16:319 Page 7 of 9of the patients had significant elevations in ALP or
serum bilirubin, which suggests that there was minimal
cholestasis. Although GGT is also considered to be a
marker of cholestasis, it can be elevated due to several
other causes including oxidative stress. Oxidative stress
has shown to occur in dengue infections, which has been
shown to associate with severity of illness [8, 32]. It has
been shown that glutathione, which is the main sub-
strate of GGT was reduced in DENV infected cells [33].
Since the GGT levels tend to increase when cellular
glutathione levels fall, the increase in GGT levels in den-
gue could be due to reduction of glutathione levels as a
result of oxidative stress [22].
Post mortem studies done in patients who had a fatal
outcome have shown that the liver is congested with liver
cell necrosis and apoptosis predominantly, in midzonal and
centrilobular areas, macrovascular steatosis and councilman
bodies, with little inflammation [7, 34, 35]. Centrilobular
liver cell necrosis is a typical feature of hypoxic hepatitis,
which is the type of liver injury observed in situations of
prolonged shock [36]. Although acute liver failure has been
reported in many patients with prolonged shock due to
dengue [3], acute liver failure has also occurred in the
absence of shock [4]. In our cohort of patients with SD, the
only 3 patients who had liver transaminases elevated of
>1000 IU did not have ultrasound evidence of fluid leakage
or any rise in the haematocrit. In addition, 39.4 % ofpatients with NSD, who did not have any evidence of fluid
leakage had more than fourfold rise in their levels of liver
transaminases. Therefore, it appears that although hypoxic
injury due to reduced hepatic perfusion is probably a cause
of liver injury in dengue, other causes such as viral induced
liver cell apoptosis and immune mediated damage could
also play a role.
Studies done on IL-22 knock out mice have shown
that IL-17 plays an important role in the pathogenesis
of dengue and also stimulated neutrophil recruitment
to the liver, which was found to associate with the se-
verity of liver damage [13]. IL-17 blockade was associ-
ated with reduced dengue severity and reduced liver
transaminase levels [13]. Although this study shows
that IL-17 produced by γδT cells was pathogenic and
IL-22 produced by natural killer cells played a protect-
ive role, another study in a dengue mouse model
showed that early infiltration by NK cells was associ-
ated with apoptosis of liver cells [14]. In our cohort of
patients, we found that both IL-10 and IL-17 were
significantly elevated during early illness, before the
patients developed vascular leakage or significant liver
injury. Both cytokines were significantly elevated in pa-
tients with SD, when compared to NSD, but this differ-
ence was not observed after day 5. ALT, which is a liver
specific transaminase, was significantly associated with
IL-17 levels. Although, our data do not show that IL-17
Fig. 4 Changes in cytokine levels throughout the course of illness.
a: Changes in serum IL-10 levels in patients with SD (n = 22) and
NSD (n = 33). The lines indicate the means and standard error of
mean (SEM). b: Changes in serum IL-17 levels in patients with SD
(n = 22) and NSD (n = 33). The lines indicate the means and standard
error of mean (SEM)
Fernando et al. BMC Infectious Diseases  (2016) 16:319 Page 8 of 9or IL-10, are in fact responsible for the liver injury in
dengue, the findings suggest that it would now be im-
portant to investigate their role in more detail in acute
dengue infection.Conclusion
In summary, our results show that varying degree of
acute liver injury are common in dengue viral infec-
tions, but did not associate with the degree of viraemia
or the onset or extent of fluid leakage. Since the rise in
liver transaminase and GGT levels peaked around day
6–7, assays of liver function tests done around day 4–5
(on admission), may significantly underestimate the
degree of liver damage. Since both IL-10 and IL-17
were significantly associated with SD, and high levels
were seen very early in the illness, their role in the
pathogenesis of dengue and dengue liver injury should
be further investigated.Additional files
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